Expression of lectin-like oxidized low-density lipoprotein receptor-1 in allografted hearts

Area of Science:

• Immunology
• Cardiovascular Biology
• Transplantation Science

Background:

• Post-transplant coronary artery disease is a significant complication of cardiac transplantation, often considered a form of chronic rejection.
• The exact mechanisms driving its pathogenesis remain incompletely understood.
• Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is implicated in vascular atherosclerosis by affecting endothelial function.

Purpose of the Study:

• To investigate the expression of LOX-1 mRNA in cardiac allografts exhibiting signs of coronary obstruction.
• To determine if alloimmune responses contribute to LOX-1 upregulation in transplanted hearts.

Main Methods:

• Heterotopic cardiac transplantation was performed using allogeneic (C57BL/6 to BALB/c) and syngeneic (C57BL/6 to C57BL/6) mouse models.
• Cardiac grafts were harvested on post-transplant day 10.
• LOX-1 mRNA expression was quantified using reverse transcription polymerase chain reaction (RT-PCR).
• Histological analysis was conducted to assess vascular changes.

Main Results:

• Allografts displayed progressive weakening of heart function and significant coronary artery narrowing with mononuclear cell infiltration by day 10.
• Syngeneic grafts maintained normal function and vascular architecture.
• A marked increase in LOX-1 mRNA expression was exclusively observed in the allografts compared to syngeneic controls.

Conclusions:

• Alloimmune responses in transplanted hearts lead to the upregulation of LOX-1 mRNA.
• Elevated LOX-1 expression in cardiac allografts is associated with the development of obstructive vascular disease.
• LOX-1 may play a critical role in the progression of chronic rejection following cardiac transplantation.